Aromolaran Ademuyiwa S, Chahine Mohamed, Boutjdir Mohamed
Cardiovascular Research Program, VA New York Harbor Healthcare System, Brooklyn, NY, USA.
Departments of Medicine, Cell Biology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, NY, USA.
Handb Exp Pharmacol. 2018;246:161-184. doi: 10.1007/164_2017_53.
In the heart, voltage-gated sodium (Na) channel (Na1.5) is defined by its pore-forming α-subunit and its auxiliary β-subunits, both of which are important for its critical contribution to the initiation and maintenance of the cardiac action potential (AP) that underlie normal heart rhythm. The physiological relevance of Na1.5 is further marked by the fact that inherited or congenital mutations in Na1.5 channel gene SCN5A lead to altered functional expression (including expression, trafficking, and current density), and are generally manifested in the form of distinct cardiac arrhythmic events, epilepsy, neuropathic pain, migraine, and neuromuscular disorders. However, despite significant advances in defining the pathophysiology of Na1.5, the molecular mechanisms that underlie its regulation and contribution to cardiac disorders are poorly understood. It is rapidly becoming evident that the functional expression (localization, trafficking and gating) of Na1.5 may be under modulation by post-translational modifications that are associated with phosphorylation. We review here the molecular basis of cardiac Na channel regulation by kinases (PKA and PKC) and the resulting functional consequences. Specifically, we discuss: (1) recent literature on the structural, molecular, and functional properties of cardiac Na1.5 channels; (2) how these properties may be altered by phosphorylation in disease states underlain by congenital mutations in Na1.5 channel and/or subunits such as long QT and Brugada syndromes. Our expectation is that understanding the roles of these distinct and complex phosphorylation processes on the functional expression of Na1.5 is likely to provide crucial mechanistic insights into Na channel associated arrhythmogenic events and will facilitate the development of novel therapeutic strategies.
在心脏中,电压门控钠(Na)通道(Na1.5)由其形成孔道的α亚基及其辅助β亚基所界定,这两者对于其对心脏动作电位(AP)的起始和维持的关键贡献都很重要,而心脏动作电位是正常心律的基础。Na1.5的生理相关性还体现在以下事实上:Na1.5通道基因SCN5A的遗传性或先天性突变会导致功能表达改变(包括表达、运输和电流密度),并且通常表现为不同的心律失常事件、癫痫、神经性疼痛、偏头痛和神经肌肉疾病。然而,尽管在确定Na1.5的病理生理学方面取得了重大进展,但对其调节机制及其对心脏疾病的贡献的分子机制仍知之甚少。越来越明显的是,Na1.5的功能表达(定位、运输和门控)可能受到与磷酸化相关的翻译后修饰的调节。我们在此综述激酶(PKA和PKC)对心脏钠通道调节的分子基础以及由此产生的功能后果。具体而言,我们讨论:(1)关于心脏Na1.5通道的结构、分子和功能特性的最新文献;(2)在由Na1.5通道和/或亚基的先天性突变(如长QT综合征和Brugada综合征)所导致的疾病状态下,这些特性如何因磷酸化而改变。我们期望,了解这些独特而复杂的磷酸化过程对Na1.5功能表达的作用,可能会为钠通道相关的致心律失常事件提供关键的机制见解,并将促进新型治疗策略的开发。